Raditio Ghifiardi

    • Greater Jakarta Area, Indonesia, Indonesia
  • Work Owner at PT Dermama Biotechnology Laboratory
  • Industry Medical / Health Care / Pharmaceuticals
  • Website yayasan-bioteknologi.org
  • About With the future of medicine lies on regenerative and gene therapy, we are proud that we are the first human stem cell company established in Indonesia and our future is limitless. Our vision is to help those who need including people with chronic and critical deseases, as well as helping people to improve their knowledge in stem cell therapy. Thus, people will realize the importance of stem cell as the therapeutic medicine and be willing to take advantage of the effectiveness to chronic and critical deseases. We also hope that one the most important goal is our social responsibility in helping the poor to improve their quality of lives. Our mission is to be the best and the biggest
LinkedIn
Tags (55)

animal application biotechnology and pharmaceuticals boy brain damage case reports children clinical application clinical trial cloning dermatology dmd growth factor hypoxic indonesia kazuo laboratorium lupus mesenchymal stem cell muscular dystrophy regenerative medicine stem cell stem cell therapy stem cell. aape therapy wound healing more…

aape aging animal application biotechnology and pharmaceuticals boy brain brain damage cancer case reports catalog cerebral palsy children clinical application clinical trial cloning dental dermama dermatology diabetes mellitus type 2 dmd enzyme ethics foot ulcers growth factor human umblilical cord blood - stem cell hypoxic immoral indonesia kazuo laboratorium leprosy lupus mesenchymal stem cell micro environment morality msc multiple fracture thoracalis bones muscular dystrophy otak sehat paradigma pengobatan product prp regenerative medicine research and development skin care stem cell stem cell therapy stem cell. aape stress telomerase therapy traffic accident umblilical cord wound healing …less

Raditio Ghifiardi's updates Load more

Likes

  • Loading Loading..